Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Korean Journal of Hematology ; : 150-153, 2012.
Article Dans Anglais | WPRIM | ID: wpr-720180

Résumé

Interdigitating dendritic cell sarcoma (IDCS) is a very rare and aggressive neoplasm that arises from antigen presenting cells. IDCS usually involves lymph nodes; however, extra-nodal involvement has also been reported. Because a consistent standard therapy for IDCS has not been established to date, we report a case of the successful treatment of disseminated IDCS using ABVD chemotherapy (doxorubicin, bleomycin, vinblastine, and dacarbazine). A 64-year-old man was diagnosed with IDCS on the basis of immunohistochemical findings of a biopsy specimen of the inferior nasal concha. Immunohistochemical staining showed a positive reaction for CD68, leukocyte common antigen, and S-100 protein, but a negative reaction for CD34, CD1a, and CD21. Imaging studies showed cervical and axillary lymphadenopathies, subcutaneous nodules, and a soft tissue lesion in the nasal cavity. Treatment with the ABVD regimen resulted in complete remission after 8 cycles of chemotherapy.


Sujets)
Humains , Adulte d'âge moyen , Cellules présentatrices d'antigène , Antigènes CD45 , Biopsie , Bléomycine , Dacarbazine , Sarcome à cellules dendritiques interdigitées , Cellules dendritiques , Fosse nasale , Protéines S100 , Cornets , Vinblastine
SÉLECTION CITATIONS
Détails de la recherche